- Global Pharma News & Resources

Proton Therapy Market: Ready to Record $1.6 Billion by 2031, Says AMR

Proton therapy is an advanced form of radiation therapy used in cancer treatment. Unlike traditional radiation therapy, which uses X-rays or photons, proton therapy utilizes protons, which are charged particles. The unique characteristic of protons allows for precise targeting of tumors while minimizing damage to surrounding healthy tissues. Proton therapy delivers a concentrated dose of radiation to the tumor, reducing the risk of side effects and long-term complications. This highly targeted approach makes proton therapy particularly beneficial for treating tumors in sensitive areas or in pediatric patients, where minimizing radiation exposure to healthy tissues is crucial.

Proton therapy differs from traditional radiation therapy in that it uses a more precise form of radiation that is less likely to damage healthy tissue surrounding the tumor. This makes it an attractive treatment option for certain types of cancer, such as tumors located near critical structures, such as the eyes, spinal cord, or brain. The global proton therapy market size $438.33 million in 2021, and is projected to reach $1.6 billion by 2031, growing at a CAGR of 13.65% from 2022 to 2031.

Download Free Sample Updated PDF: (Including Full TOC, Table & Figures) –

Proton Therapy Market in Short:

CAGR: 13.65%
Current Market Size: USD 1.6 Billion
Fastest Growing Region: APAC
Largest Market: North America
Projection Time: 2021-2031
Base Year: 2031

What are the upcoming trends of Proton Therapy Market in the world?

Trends of Proton Therapy Market include increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices.

What is the leading application of Proton Therapy Market?

Central nervous system cancer is the leading application of Proton Therapy Market.

Value Propositions Related to The Report:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

Covid-19 Situation –

  • The COVID-19 pandemic had a slight negative impact on the growth of the global proton therapy market, especially in the early stages.
  • However, the market picked up quickly as the demand for proton therapy grew to support the regular patient population requiring radiation therapy.

Inquire Your Every Doubt Here:

During proton therapy, the patient lies on a treatment table while a machine, called a synchrotron or a cyclotron, delivers a precise and highly focused beam of protons to the target area. The protons penetrate the tumor, delivering a high dose of radiation, and then stop, reducing the exposure of surrounding healthy tissue.

Proton therapy is a relatively new and developing field and is not yet widely available. It is typically used as a secondary treatment after surgery or chemotherapy, and is most commonly used to treat cancers such as prostate cancer, lung cancer, and pediatric cancers.

The side effects of proton therapy are typically mild and may include fatigue, skin irritation, or changes in bowel or bladder function. The long-term effects of proton therapy are not well understood, and more research is needed to fully evaluate its benefits and risks.

Major Key Market Players in the Industry –

  • Hitachi, Ltd.,
  • Ion Beam Applications S.A.,
  • Mevion Medical Systems,
  • Mirion Technologies Ltd.,
  • Optivus Proton Therapy, Inc.,
  • Provision Healthcare,
  • Pro Tom International,
  • Siemens,
  • Sumitomo Heavy Industries, Ltd., and
  • Toshiba Corporation.

Market: By Region Outlook

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)

Request for Customization:

Important Questions Being Answered by This Market Report Are –

Q1. What is the estimated industry size of Proton Therapy Market?

Q2. What is the leading application of Proton Therapy Market?

Q3. What are the upcoming trends of Proton Therapy Market in the world?

Q4. Which is the largest regional market for Proton Therapy Market?

Key findings of the study –

  • Based on the forecast, the CNS cancer segment is estimated to register a CAGR of 12.41% from 2022 to 2031.
  • Based on product type, the automotive segment is expected to register a CAGR of 13.21% from 2022 to 2031.
  • From the end user perspective, the hospital sector is expected to register a CAGR of 13.8% from 2022 to 2031.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Editor Details

  • Company:
    • The Wire Times
Last Updated: 15-May-2023